Pre-Meeting Symposium
Cardiometabolic Health in Midlife Women
The North American Menopause Society (NAMS) designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are also available.
Learning Objectives
By participating in this activity, attendees should be able to
- Understand cardiovascular disease symptoms and novel risk factors in women
- Evaluate recommendations for beginning statins and specific risk factors in women
- Become familiar with the medical management of obesity
- Appreciate the disparities in care in women’s heart health
- Recognize the cardiovascular consequences in women with diabetes
- Explore food as medicine for cardiometabolic health
Annual Meeting
NAMS 2021: The State of Midlife Women’s Health Today
The North American Menopause Society (NAMS) designates this live activity for a maximum of 21.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 8.75 pharmacotherapeutic hours are also available.
Learning Objectives
By participating in this activity, attendees should be able to
- Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause
- Understand the science of how the brain steers you through menopause
- Discuss the intersection of research health policy and clinical care
- Become familiar with breast cancer prevention, screening, and survivorship care
- Manage menopause in a pandemic and recognize the collateral damage of COVID-19
- Evaluate bone health and identify how to prevent the first fracture
- Explore the promises and challenges of gene editing in the age of CRISPR
- Establish what is abnormal uterine bleeding in perimenopausal and postmenopausal women
- Analyze what’s new in cervical cancer screening and sexually transmitted infections
- Interpret the issues surrounding hair loss and voice changes
- Define female sexual function and when and how to use androgens
- Appreciate the art of end-of-life care
- Assess hormonal migraines, migraines at menopause, and treatment options
- Review the risks and benefits of starting hormone therapy at menopause